Sonoma Pharmaceuticals Inc (SNOA) Stock Price, Quote & News

Company Profile

Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild t...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 800 759 9305

Website: sonomapharma.com

Address:

5445 Conestoga Court, Suite 150, Boulder, United States

Bunster Aug. 8 at 3:55 PM

$SNOA TELL NOSHAME BAGHOLDER PUMPER SNOA NET LOSS FOR THE Q ENDED JUNE 30 1.24 MILLION DOLLARS EVEN WITH THE ENGLAND STORES BEING ONLINE DURING THE Q VERY POOR FOLKS VERY POOR .AMY. ..ANOTHER LOSING Q AMY PPS PRE RS IS 15 PENNIES FOLKS 15 PENNIES

0 · Reply

noname10000 Aug. 8 at 11:13 AM

$SNOA $3,600,000 in cash

0 · Reply

Josefo1984 Aug. 7 at 9:43 PM

$SNOA https://ir.sonomapharma.com/press-releases/detail/431/sonoma-pharmaceuticals-reports-first-fiscal-quarter-2026

0 · Reply

noname10000 Aug. 7 at 9:26 PM

$SNOA

0 · Reply

noname10000 Aug. 7 at 9:22 PM

$SNOA

0 · Reply

noname10000 Aug. 7 at 9:20 PM

$SNOA

0 · Reply

Bunster Aug. 7 at 7:04 PM

$SNOA bee good to prime ah and put an er out that is like no other u have ever put out AMY. i will take anything thats better then last q.

0 · Reply

noname10000 Aug. 5 at 11:02 AM

$SNOA earnings soon

0 · Reply

Bunster Aug. 5 at 10:56 AM

$SNOA @BarelySocialGator hmm

0 · Reply

Bunster Aug. 5 at 10:55 AM

$SNOA HEY BARELY SOCIAL IF U HADNT BLOCKED ME ,ONE OF THE BEST POSTERS HERE, MAYBE THE 3.41 WOULD COME DOWN!!!!!!!!!!!!!!!!!!!!!!!!

0 · Reply

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results

Jun 17, 2025, 4:10 PM EDT - 7 weeks ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results

Apr 22, 2025, 4:01 PM EDT - 3 months ago

Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain

Mar 10, 2025, 4:01 PM EDT - 5 months ago

Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)

Feb 25, 2025, 4:01 PM EST - 5 months ago

Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando

Feb 5, 2025, 4:05 PM EST - 6 months ago

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results

Dec 5, 2024, 8:30 AM EST - 8 months ago

Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices

Nov 21, 2024, 4:06 PM EST - 9 months ago

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States

Nov 11, 2024, 4:20 PM EST - 9 months ago

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel

Nov 7, 2024, 8:45 AM EST - 9 months ago

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results

Oct 31, 2024, 4:01 PM EDT - 10 months ago

Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf

Oct 22, 2024, 8:35 AM EDT - 10 months ago

Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada

Oct 21, 2024, 4:01 PM EDT - 10 months ago

Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences

Sep 19, 2024, 8:30 AM EDT - 11 months ago

Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

Sep 17, 2024, 8:30 AM EDT - 11 months ago

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution

Sep 11, 2024, 8:30 AM EDT - 11 months ago

Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line

Aug 28, 2024, 6:10 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock

Aug 26, 2024, 8:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff

Aug 21, 2024, 8:45 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States

Aug 8, 2024, 4:10 PM EDT - 1 year ago

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results

Jul 9, 2024, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine

Jun 17, 2024, 5:00 PM EDT - 1 year ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results

May 9, 2024, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores

Apr 9, 2024, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States

Apr 4, 2024, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections

Mar 28, 2024, 4:01 PM EDT - 1 year ago

Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences

Mar 27, 2024, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals

Feb 8, 2024, 4:10 PM EST - 1 year ago

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results

Jan 23, 2024, 7:30 AM EST - 1 year ago

Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use

Jan 9, 2024, 9:15 AM EST - 1 year ago

NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor Network

NBY

Nov 13, 2023, 4:10 PM EST - 1 year ago

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results

Nov 3, 2023, 7:30 AM EDT - 1 year ago

Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference

Oct 26, 2023, 9:10 AM EDT - 1 year ago

Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock

Aug 15, 2023, 7:30 AM EDT - 2 years ago

National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

Aug 10, 2023, 4:15 PM EDT - 2 years ago

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial Results

Aug 3, 2023, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board

Jun 22, 2023, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial Results

Jun 9, 2023, 5:05 PM EDT - 2 years ago

Sonoma Pharmaceuticals Shares Soar 44% After Introducing New Product

Jun 8, 2023, 4:01 PM EDT - 2 years ago

Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European Union

Apr 11, 2023, 7:30 AM EDT - 2 years ago

Sonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot Care

Mar 28, 2023, 4:15 PM EDT - 2 years ago

Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI North America Conference in Philadelphia

Mar 2, 2023, 7:30 AM EST - 2 years ago

Sonoma Pharmaceuticals and MicroSafe Group Announce New EPA Claims and Green Seal Certification for Nanocyn(R) Hospital-Grade Disinfectant

Feb 14, 2023, 4:30 PM EST - 2 years ago

Sonoma Pharmaceuticals Reports Third Quarter 2023 Financial Results

Jan 31, 2023, 7:30 AM EST - 2 years ago

Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea

Jan 25, 2023, 7:30 AM EST - 2 years ago

Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx Products

Jan 4, 2023, 7:30 AM EST - 2 years ago

Sonoma Pharmaceuticals Launches Two New Products Expanding Its Line of Office Dispense Products Exclusively for Dermatologists and Medical Spas

Nov 14, 2022, 4:15 PM EST - 2 years ago

Sonoma Pharmaceuticals Reports Second Quarter 2023 Financial Results

Oct 27, 2022, 4:01 PM EDT - 3 years ago

Sonoma Pharmaceuticals Launches Two New Dermatological Products for Over-The-Counter Use in the United States

Oct 6, 2022, 4:15 PM EDT - 3 years ago

Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI Conference in Frankfurt, Germany

Aug 11, 2022, 4:30 PM EDT - 3 years ago

Sonoma Pharmaceuticals Reports First Quarter 2023 Financial Results

Bunster Aug. 8 at 3:55 PM

0 · Reply

noname10000 Aug. 8 at 11:13 AM

$SNOA $3,600,000 in cash

0 · Reply

Josefo1984 Aug. 7 at 9:43 PM

$SNOA https://ir.sonomapharma.com/press-releases/detail/431/sonoma-pharmaceuticals-reports-first-fiscal-quarter-2026

0 · Reply

noname10000 Aug. 7 at 9:26 PM

$SNOA

0 · Reply

noname10000 Aug. 7 at 9:22 PM

$SNOA

0 · Reply

noname10000 Aug. 7 at 9:20 PM

$SNOA

0 · Reply

Bunster Aug. 7 at 7:04 PM

$SNOA bee good to prime ah and put an er out that is like no other u have ever put out AMY. i will take anything thats better then last q.

0 · Reply

noname10000 Aug. 5 at 11:02 AM

$SNOA earnings soon

0 · Reply

Bunster Aug. 5 at 10:56 AM

$SNOA @BarelySocialGator hmm

0 · Reply

Bunster Aug. 5 at 10:55 AM

$SNOA HEY BARELY SOCIAL IF U HADNT BLOCKED ME ,ONE OF THE BEST POSTERS HERE, MAYBE THE 3.41 WOULD COME DOWN!!!!!!!!!!!!!!!!!!!!!!!!

0 · Reply

BarelySocialGator Aug. 5 at 9:02 AM

$SNOA Whoever has the $3.41 ask out there, take it down. You're screwing up my plan.

0 · Reply

noname10000 Aug. 5 at 1:54 AM

$SNOA right direction

0 · Reply

noname10000 Aug. 4 at 1:37 PM

$SNOA earnings soon

0 · Reply

noname10000 Aug. 1 at 3:47 PM

$SNOA just some real volume and the beauty will spike...as usual.

0 · Reply

ItTakesItAll Aug. 1 at 2:24 PM

My Dear Investors: look out for opportunities in days such as today. Many opportunities up there. Ugly to Beauty in progress and one by one will blown like a rose 🎈 $IVF $CETX $ENSC $SNOA $PTIX INTS and others lets see who's the first 100%+ with bonus😅🎈 Safe and profitable trades and happy wkd 🥰

1 · Reply

noname10000 Aug. 1 at 1:36 PM

$SNOA time to change direction honey

0 · Reply

Bunster Jul. 31 at 8:35 PM

$SNOA PUMPING BAGHOLDER noshame thanked the people who sold him high priced shares over the last month. THEY SAID U R WELCOME NOSHAME AND THANKU FOR BUYING OUR BAGS FROM US!!!!!!!!!!!!!!

0 · Reply

noname10000 Jul. 31 at 6:52 PM

$SNOA loading again

0 · Reply

noname10000 Jul. 31 at 3:20 PM

$SNOA time for some news

0 · Reply

noname10000 Jul. 31 at 2:13 PM

$SNOA let go

0 · Reply

noname10000 Jul. 31 at 12:39 PM

$SNOA almost ready

0 · Reply

ItTakesItAll Jul. 30 at 4:41 PM

$REPL 185%+ 2.79-8.07🎈🔥🥰😎🙏🏼⛱️🌊🏌️⛳️ ugly once, beauty now! $PTIX $SNOA $IVF looking good for a beauty treatment 😅☀️✅🔥

0 · Reply

Market Cap	5.03M
Revenue (ttm)	14.29M
Net Income (ttm)	-3.46M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-24.21%
Debt to Equity Ratio	0.00

Volume	20,000
Avg Vol	65,844
Day's Range	N/A - N/A
Shares Out	1.64M
Stochastic %K	49%
Beta	1.25
Analysts	Strong Sell
Price Target	$14.80